Transrectal ultrasound-guided transperineal cryoablation in the treatment of XXXX : preliminary results.

@entity1 @entity323 @entity263 @entity322 @entity1494 @entity5 @entity189 @entity1876 @entity1486
PURPOSE: We studied ultrasound-guided percutaneous cryoablation for treatment of @entity263 . MATERIALS AND METHODS: Our series includes 83 individuals who underwent transrectal ultrasound-guided transperineal percutaneous cryoablation of the prostate. @entity1486 levels, biopsy results and complications were assessed at 3 months. RESULTS: Of 61 biopsies 8 (13.1%) were positive for @entity189 (half showed stage D disease). Of @entity1 with stages T1 to T3 @entity5 92.6% were free of disease at 3 months. @entity1486 levels were significantly decreased by an average of 1.90 ng./ml. (p < 0.05). Major complications were infrequent, including @entity1494 in 1 @entity1 , urethral strictures in 3, @entity1876 and partial @entity322 in 2. @entity323 was frequent but transient. CONCLUSIONS: Transrectal ultrasound-guided transperineal percutaneous cryoablation of the prostate produces few major complications and appears at 3 months to be effective in eradicating @entity263 . Longer followup is required to test the original hypothesis.
